OmniAb (OABI) Shares Outstanding (2021 - 2026)
OmniAb (OABI) reported Shares Outstanding of $144.8 million for Q1 2026, up 18.54% year-over-year from $122.1 million in Q1 2025, and little changed quarter-over-quarter from $144.3 million in Q4 2025.
OmniAb (OABI) Shares Outstanding (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Shares Outstanding data on file, last reported at $144.8 million in Q1 2026.
- Shares Outstanding for Q1 2026 came in at $144.8 million, up 18.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $144.8 million (up 18.54% YoY), and the FY2025 annual result was $144.3 million, up 18.68% from the prior year.
- Shares Outstanding held at $144.8 million in Q1 2026 per OABI's latest filing, from $144.3 million in the prior quarter.
- Over five years, Shares Outstanding peaked at $144.8 million in Q1 2026 and troughed at $5.8 million in Q1 2022.
- A 5-year average of $104.1 million and a median of $117.4 million in 2024 frame the typical range for Shares Outstanding.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding changed 0.0% in 2022, then soared 1920.03% in 2023.
- A 5-year view of Shares Outstanding shows it stood at $115.2 million in 2022, then increased by 1.42% to $116.9 million in 2023, then gained by 4.06% to $121.6 million in 2024, then advanced by 18.68% to $144.3 million in 2025, then increased by 0.33% to $144.8 million in 2026.
- Business Quant data shows OABI's Shares Outstanding at $144.8 million in Q1 2026, $144.3 million in Q4 2025, and $144.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | OmniAb | 291.12 Mn | 248.15 Mn | 14.41 Mn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Mar 31, 2026 | 144.78 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Dec 31, 2025 | 144.31 Mn |
| Sep 30, 2025 | 143.96 Mn |
| Sep 30, 2025 | 143.96 Mn |
| Sep 30, 2025 | 143.96 Mn |
| Sep 30, 2025 | 143.96 Mn |